MedMira Announces Leadership Transition

Hermes Chan to Succeed Stephen Sham as CEO

26-Jul-2006

MedMira Inc. announced that Stephen Sham will retire as Chief Executive Officer, a position he has held since the company's inception 12 years ago. Mr. Sham will continue in his role as Chairman of the Board of Directors. The CEO role will immediately transition to Hermes Chan, who has been appointed by the Board of Directors. Mr. Chan, the company's co-founder, has served as President & COO of MedMira for the past two years.

Mr. Chan will assume the role of CEO and continue to serve as President of MedMira. He is the inventor of MedMira's core technology platform, upon which all of the company's rapid tests are developed. Mr. Chan moved up through the management ranks of the company including positions of Research Scientist, General Manager, and Senior Vice President. Prior to joining MedMira in 1994, Mr. Chan worked with another Nova Scotia biotechnology company.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances